Skip to main content
. 2016 Sep 30;7(45):74171–74188. doi: 10.18632/oncotarget.12367

Figure 7. VV-GMCSF-Lact delays growth of MDA-MB-231 breast tumor xenografts.

Figure 7

MDA-MB-231 tumor-bearing mice were intravenously injected with 1×107 PFU/100 μl saline VV-GMCSF-Lact, VV-GMCSF-dGF or saline as a control. A. – The growth rate of MDA-MB-231 tumors. Arrows indicate the days of virus injections. The asterisks indicate a significant difference between groups (p < 0.01). B. – Tumors were excised on day 74 and weighed. Data are presented as mean tumor weight (mg) ± SE. C. – Mice were photographed on final day of experiment.